Conflict of Interest
Conflict of Interest Policy
What authors, reviewers and editors must declare as competing interests at ASSRJ, and how undeclared conflicts are handled.
A conflict of interest exists when professional judgement concerning a primary interest (such as the validity of research) may be influenced by a secondary interest (such as financial or personal gain). Declaring conflicts does not imply wrongdoing — but failing to declare them does. This policy applies to authors, reviewers and editors.
What must be declared
Conflicts may be financial or non-financial, including but not limited to:
| ▸ | employment, consultancies, honoraria, paid expert testimony or advisory roles; |
| ▸ | grants, stock or share ownership, patents or royalties; |
| ▸ | membership of boards or organisations with an interest in the work; and |
| ▸ | close personal or family relationships, academic rivalry, advocacy roles, or strongly held beliefs relevant to the subject. |
In the social sciences, also consider funding or sponsorship from organisations with a stake in the findings, and a close relationship with a community or institution being studied.
Authors
Authors must include a Conflict of Interest statement declaring all relevant interests of every author, or stating: “The authors declare no conflicts of interest.” All funding sources must also be disclosed. Undeclared conflicts discovered after publication may lead to a correction or, in serious cases, retraction.
Reviewers
Reviewers must decline to review, or promptly inform the editor, where they have a conflict — for example recent collaboration or rivalry with the authors, a financial interest in the outcome, or any relationship that could bias their assessment.
Editors
Editors must not handle manuscripts in which they have a competing interest, including those authored by themselves, close colleagues or collaborators; such manuscripts are reassigned. Editorial Board members’ submissions are subject to the same independent process as any other and receive no preferential treatment.
